Last reviewed · How we verify
Dexmedetomidine Hydrochloride Nasal Spray
Dexmedetomidine Hydrochloride Nasal Spray is a Small molecule drug developed by Shanghai Hengrui Pharmaceutical Co., Ltd.. It is currently FDA-approved.
At a glance
| Generic name | Dexmedetomidine Hydrochloride Nasal Spray |
|---|---|
| Sponsor | Shanghai Hengrui Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status (PHASE3)
- Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monitoring Settings (PHASE4)
- Role of Airway Topicalization in Awake Fiberoptic Intubation (PHASE3)
- Effect of Perioperative Dexmedetomidine on Chronic Post-Surgical Pain (PHASE4)
- A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children (PHASE3)
- A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults (PHASE2, PHASE3)
- A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine Hydrochloride Nasal Spray CI brief — competitive landscape report
- Dexmedetomidine Hydrochloride Nasal Spray updates RSS · CI watch RSS
- Shanghai Hengrui Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Dexmedetomidine Hydrochloride Nasal Spray
What is Dexmedetomidine Hydrochloride Nasal Spray?
Dexmedetomidine Hydrochloride Nasal Spray is a Small molecule drug developed by Shanghai Hengrui Pharmaceutical Co., Ltd..
Who makes Dexmedetomidine Hydrochloride Nasal Spray?
Dexmedetomidine Hydrochloride Nasal Spray is developed and marketed by Shanghai Hengrui Pharmaceutical Co., Ltd. (see full Shanghai Hengrui Pharmaceutical Co., Ltd. pipeline at /company/shanghai-hengrui-pharmaceutical-co-ltd).
What development phase is Dexmedetomidine Hydrochloride Nasal Spray in?
Dexmedetomidine Hydrochloride Nasal Spray is FDA-approved (marketed).